The Photometics ScanStar demonstrates the first known use of an ultrashort pulse laser in cancer therapeutics. The Photometics ScanStar was developed to administer Selective Photo-Apoptosis in a clinical setting.
Photometics has developed a uniquely effective therapy for Basal Cell Carcinoma, the most common form of skin cancer, affecting more than 1 million Americans annually.
600 1st Ave, Suite 442
Seattle, WA 98104